Highest return-on-assets companies
Companies ranked by trailing return on assets (ROA) — how efficiently a business turns its asset base into profit. Delayed fundamentals from market data, shown with their as-of date.
Ranked by ROA: companies 2,976–3,000 of 3,067.
| # | Company | Sector | ROA | Net margin | Market cap |
|---|---|---|---|---|---|
| 2976 | Hyperfine Inc Class A (HYPR) | Health Care | -64.4% | -262.3% | $76M |
| 2977 | Neighborhood Intelligence Inc (NXH) | Consumer Discretionary | -64.4% | -18.6% | $183M |
| 2978 | Kodiak Sciences Inc (KOD) | Health Care | -65.4% | n/a | $6.2B |
| 2979 | Bakkt Inc Class A (BKKT) | Financials | -65.9% | -4.6% | $194M |
| 2980 | Avalo Therapeutics Inc (AVTX) | Health Care | -67.2% | -132642.4% | $401M |
| 2981 | Rocket Pharmaceuticals Inc (RCKT) | Health Care | -67.5% | n/a | $262M |
| 2982 | CAMP4 Therapeutics Corporation (CAMP) | Health Care | -68.2% | -2298.5% | $255M |
| 2983 | Rezolute Inc (RZLT) | Health Care | -68.8% | n/a | $375M |
| 2984 | Pacific Biosciences of California Inc (PACB) | Health Care | -69.7% | n/a | $706M |
| 2985 | ImmunityBio Inc (IBRX) | Health Care | -70.0% | -310.2% | $9.2B |
| 2986 | Palvella Therapeutics Inc (PVLA) | Health Care | -70.0% | 43.7% | $2.6B |
| 2987 | Equillium, Inc. (EQ) | Health Care | -70.2% | -19.6% | $96M |
| 2988 | Prelude Therapeutics Incorporated (PRLD) | Health Care | -70.4% | -819.6% | $287M |
| 2989 | Angel Studios, Inc. (ANGX) | Communication Services | -70.6% | -53.0% | $633M |
| 2990 | Hinge Health Inc Class A (HNGE) | Health Care | -70.9% | -89.9% | $9.3B |
| 2991 | Alico Inc (ALCO) | Consumer Staples | -73.1% | -334.3% | $275M |
| 2992 | Spruce Biosciences Inc (SPRB) | Health Care | -73.5% | n/a | $134M |
| 2993 | Z Squared Inc (ZSQR) | Health Care | -73.8% | -874.3% | $178M |
| 2994 | Annexon Inc (ANNX) | Health Care | -74.5% | n/a | $796M |
| 2995 | Prothena Corporation plc (PRTA) | Health Care | -74.7% | -2520.6% | $409M |
| 2996 | Solid Biosciences Inc (SLDB) | Health Care | -75.0% | -1062.3% | $736M |
| 2997 | Strive Inc Class A (ASST) | Health Care | -76.5% | -3406.5% | n/a |
| 2998 | UroGen Pharma Ltd (URGN) | Health Care | -76.6% | -139.8% | $1.2B |
| 2999 | NextNav Inc (NN) | Information Technology | -76.6% | -4138.5% | $1.5B |
| 3000 | Pulse Biosciences Inc (PLSE) | Health Care | -77.0% | -20794.6% | $3.9B |
Find more highest return-on-assets companies like these →
Data: SEC EDGAR (filings) + market data (fundamentals, delayed daily-close). Every figure is shown with its as-of date on the company page; a company with no data for this metric is excluded from the ranking, never estimated.
Last updated 2026-11-06 — rankings shift as the underlying data refreshes.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.